Gene therapy involves delivering therapeutic DNA into a patient's cells to treat disease. It was first conceptualized in 1972 and the first FDA-approved gene therapy for ADA-SCID occurred in 1990. Gene therapy targets diseases without other treatments, such as immune disorders, cystic fibrosis, and hemophilia. There are two main types - somatic gene therapy modifies body cells while germline modifies sperm or eggs. Viral and non-viral vectors are used to deliver genes in vivo or ex vivo gene therapy methods.